CTGCT (Centre for the Technologies of Gene and Cell Therapy)

🧬 CCDR Centro is the public authority coordinating regional development in Portugal’s Centro Region.

In GeneH, they help align policy priorities and stakeholders to strengthen the ecosystem and enable sustainable collaboration and real-world uptake.

@kemijski.bsky.social
@ctgct.bsky.social

🧠 The Blood–Brain Barrier protects the brain, but also blocks out many medicines. In GeneH Deliverable 5.1, our Joint Research Program advances precision of genetic tools and smart delivery strategies to reach CNS cells. Article: www.uc.pt/en/geneh/new...

@kemijski.bsky.social
@ctgct.bsky.social

CTGCT at the 12th National Rare Disease Day Conference - CTGCT On Friday, February 27, 2026, part of our team joined experts, decision-makers, and patient advocates at the 12th National Rare Disease Day Conference held at the Congress Center Brdo pri Kranju.The e...

The #CTGCT team joined the 12th National Rare Disease Day Conference.
Highlights:
✅ #Urbagen: 1st Slovenian rare disease drug milestone
✅ @genehproject.bsky.social : Proud partners in patient-centric research
✅ Bridging the gap from lab to bedside
ctgct.si/en/objave/12...
#RareDiseaseDay #Slovenia

Remote-Controlling the Cell: The Future of Precision Medicine? - CTGCT Imagine if we could talk to our cells the same way we talk to a smart home device. We could tell a cell to start producing a specific medicine only when it’s needed or order a group of cells to shift ...

Can we "remote-control" our cells?

Researchers led by @rjerala.bsky.social at @kemijski.bsky.social have developed a way to turn genes on/off using human hormone receptors and "lava lamp" physics.

Read more:
ctgct.si/en/objave/re...

#SyntheticBiology

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

New positions alert! We are #hiring at the #CTGCT. Don't miss this chance to join our team
ctgct.si/en/jobs/

CTGCT Science Talks March - Dr. Ajasja Ljubetič - CTGCT On Monday, 2nd of March 2026, 2:00 PM (Ljubljana/Berlin time),Dr. Ajasja Ljubetič, Research Assistant Processor and group leader in the Department of Synthetic Biology and Immunology at the National I...

Join us on the #CTGCT #Science_Talks #webinar

We’re pleased to host Dr.@ajasjaljubetic.bsky.social from Dept. Syn. Bio and Immuno. at the @kemijski.bsky.social . He will present his work titled “Overview of de novo protein design (and design of novel binders)”.

ctgct.si/en/objave/ct...

Success for #GeneH is a stronger 4-helix ecosystem, closer PT–SI collaboration and concrete examples of gene therapy innovations moving towards patients.

🎥 New video out now: youtu.be/DSkV0_tDEzM
#ResearchToPatients #EUProjects

@kemijski.bsky.social
@ctgct.bsky.social

Today is PUST (carnival) in Slovenia and some of the brave members of the CTGCT dared to come to the office (or WFH) in full costume!

May the #krof be in you, Happy #Pust!

Can you guess all costumes?

Molecular Surgery: How Base Editors are Rewriting the Future of Cancer Therapy - CTGCT Imagine being able to open the "instruction manual" of a human cell and fix a single typo that causes a life-threatening disease. This is no longer science fiction; it is the reality of base editors, ...

Can we "erase" cancer by fixing a single DNA typo?

Dr. Sayed, from @tudresden.bsky.social, is pioneering the use of CRISPR base editors to rewrite mutations in the P53 gene, the "guardian of the genome."

Read how this technology is the future of personalized medicine: ctgct.si/en/objave/mo...

GeneH partners published a new article on Action & Investment Plan. 4-stage roadmap from Discovery → Testing → Scaling up → Clinical trials + tools.

Read more: www.uc.pt/en/geneh/new...

#GeneH #GeneTherapy #HorizonEurope #RareDiseases

@kemijski.bsky.social
@ctgct.bsky.social

Just 3 weeks left to apply for these positions!

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

New year, new teammates at #CTGCT! 🥼

We are hiring 5 key roles at @kemijski.bsky.social:

🧬 2x GMP Experts: PhD + 4yrs exp. in bioprocess/QA.
🔬 3x Postdoc Researchers: PhD + 3yrs postdoc exp. preferred.

📅 Deadline: Feb 19, 2026
Details: ctgct.si/en/jobs/

#Hiring #GeneTherapy

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

New year, new teammates at #CTGCT! 🥼

We are hiring 5 key roles at @kemijski.bsky.social:

🧬 2x GMP Experts: PhD + 4yrs exp. in bioprocess/QA.
🔬 3x Postdoc Researchers: PhD + 3yrs postdoc exp. preferred.

📅 Deadline: Feb 19, 2026
Details: ctgct.si/en/jobs/

#Hiring #GeneTherapy

CTGCT Science Talks February - Dr. Shady Sayed - CTGCT On Monday, 2nd of February 2026, 2:00 PM (Ljubljana/Berlin time), Dr. Shady Sayed from the Department of Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, GermanyFil...

Join us on the #CTGCT #Science_Talks #webinar

We’re pleased to host Dr. Shady El-Husseiny,TU Dresden. He will present his work titled “Application of CRISPR base editors in innovative cancer therapies”.

ctgct.si/en/objave/ct...

Boosting Immunity After Transplantation: The Future of Automated T-Cell Therapy - CTGCT For patients undergoing a life-saving organ transplant, the road to recovery is often a delicate balancing act. While the new organ offers a second chance, the drugs needed to prevent the body from re...

Can automation revolutionize viral defense after transplant? 🧬
At #CTGCT #ScienceTalks, Claudia Beltran Mestres from Charité Berlin shared how automated G-Rex bioreactors produce "fitter" T-cells to fight viral infections after a transplant.

Article: ctgct.si/en/objave/bo...

Ceremonial Signing of the Agreement on Co-Financing of the CTGCT - CTGCT We are proud to announce a historic milestone for our project. On December 22, 2025, the Minister of Higher Education, Science, and Innovation, Dr. Igor Papič, and the Director of the National Institu...

🚀 Big news!

The #CTGCT co-financing agreement is signed. This €30M joint investment (EU + Slovenia) will help translating knowledge into clinical practice.

Led by Dr. Mojca Benčina, we’re: 🔬 Advancing therapies 🥼 Bringing talent home 🤝 Partnering globally

Full story: ctgct.si/en/objave/ce...

Don't forget to sign up for this webinar!

Bluepharma (Industry helix): CRDMO enabling formulation-to-GMP transitions. Advanced Therapies Hub for mRNA delivery and a new sterile unit (dual lines) support flexible clinical-supply strategies within GeneH.

→ www.uc.pt/geneh/

@kemijski.bsky.social
@ctgct.bsky.social

JAFRAL joins GeneH’s Industry helix: CDMO for phages, plasmid DNA, mRNA. GMP clean rooms, fill-and-finish, QA/QC and CMC packages enable GMP-ready materials for tox and early clinical use—supporting GeneH translation.
→ www.uc.pt/geneh/

@kemijski.bsky.social
@ctgct.bsky.social

CTGCT Newsletter No. 3 - Happy Holidays to everyone! - CTGCT As the year wraps up, we want to share our third official CTGCT newsletter, summarizing a period of great growth, both in our team size and our scientific impact!In the last six months, we have experi...

#CTGCT #Newsletter No. 3 is out!
From making space for our new facility to hosting our CTGCT Days, it’s been a massive year.

Catch up on:
Team expansion
#CTGCTDays2025 highlights
Latest open-access research
Plans for 2026 and more

ctgct.si/en/objave/ct...

Building a Sustainable Future: CTGCT at the 4th Teaming Club Conference in Porto - CTGCT The CTGCT played an active role in these high-level discussions, represented by our colleague Vesna. She served as a speaker in the panel Common Challenges & Solutions in a parallel thematic session o...

The CTGCT was at the 4th Teaming Club Conference in Porto by BIOPOLIS, tackling long-term sustainability for Centres of Excellence! 🔬

We discussed: Activating the Quadruple Helix and Retaining international talent (Team culture is key!)

Read our full article for insights! ctgct.si/en/objave/4t...

CTGCT Science Talks January - Claudia Beltran Mestre - CTGCT On the 12th of January 2026, Claudia Beltran Mestre, from the Berlin Center for Advanced Therapies at Charité Universitätsmedizin Berlin will present in our CTGCT Science Talks webinar series. The tal...

Join us on 12 Jan 2026 at 14:00 (CET) for our next #CTGCT #ScienceTalks #webinar with Claudia Beltran Mestres from BeCAT at Charité Berlin on “Automation of Antiviral T cell Product Manufacturing”

🔗 Register now and get the link on the day of the event!

ctgct.si/en/objave/ct...

Bridging the Gap: The Role of GMP Simulation in ATMP Translation - CTGCT In recent decades, the medical toolbox has expanded dramatically. While traditional medicine relied on synthetic drugs (small molecules interacting with specific pathways) and later biologicals like a...

Simulation is the secret sauce for "Living Drugs"!

Aiko Ballardini from @umcutrecht.bsky.social explains how using a GMP Simulation facility helps researchers quickly transform lab ideas into safe, compliant #ATMPs for patients.

Link: ctgct.si/en/objave/br...

#Biotech #GMP #CTGCT #ScienceTalks

CTGCT at the CREATIC Conference 2025: Driving Advanced Therapy Innovation - CTGCT We were thrilled to participate in the 2nd Central European Conference for Advanced Therapy and Immunotherapy (CREATIC Conference 2025), a significant European event focusing on the advancement of Adv...

We shared our experience from the CREATIC Conference 2025! Our Head, Prof. Benčina, presented on CTGCT's progress during the Innovation in R&D session. Great networking and insights on ATMPs. Thanks MUNI CREATIC team!

Read the full recap: ctgct.si/en/objave/ct...

#CREATIC #ATMP

CTGCT Science Talks December - Aiko Ballardini - CTGCT On the 1st of December 2025, Aiko Ballardini, quality control specialist at the Innovation Center for Advanced Therapies (ICAT) of the University Medical Center Utrecht will give present in our CTGCT ...

Join us on 1 Dec 2025 at 14:00 (CET) for our next CTGCT Science Talks webinar with Aiko Ballardini from UMC Utrecht on “The role of a GMP simulation unit in ATMP translation.”

🔗 Register now and get the link on the day of the event!

ctgct.si/en/objave/ct...

Meet KI –@kemijski institut. As one of GeneH’s key research pillars, KI (via @CTGCT) turns research into GMP-ready steps and safety evidence, advancing CTNNB1 & Kleefstra toward clinical readiness with EU partners.
👉 www.uc.pt/geneh/
@kemijski.bsky.social
@ctgct.bsky.social

Making Viral Vectors Happy: Key Takeaways from Our CTGCT Science Talks Webinar - CTGCT We were thrilled to host Dr. Andrea Rayat for our recent CTGCT Science Talks webinar. Dr. Rayat, an Associate Professor in bioseparations and downstream processing at University College London, delive...

Happy viral vectors = better gene and cell therapies! 🧬

Dr. Andrea Rayat from @ucl.ac.uk shares how small tweaks in bioprocessing can boost yields & improve treatments.

ctgct.si/en/objave/ma...

#GeneTherapy #Biotech #ViralVectors

CTGCT Takeaways from the World Orphan Drug Congress Europe 2025 - CTGCT The World Orphan Drug Congress 2025 provided a clear overview of the strategic challenges facing the rare disease community, particularly the disconnect between European research and patient access. F...

Check our top takeaways from the World Orphan Drug Congress Europe 2025 in Amsterdam!

Critical discussions focused on the EU research-to-clinic gap, HTA, and tackling regulatory bottlenecks for advanced therapies.

Read the post: ctgct.si/en/objave/ct...

#RareDisease #WODC2025

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

#QC ASSISTANT #JOB_ALERT!
The #CTGCT as part of the @kemijski.bsky.social is hiring! Help us build the future of Gene & Cell Therapy by ensuring our quality system meets #GMP/cGxP standards.

Req: Master's Degree & #QC/QA experience (preferred).

Deadline: Nov 25, 2025
Learn more: ctgct.si/en/jobs/

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

📢 JOB ALERT: #CTGCT as part of @kemijski.bsky.social is expanding! 🧬

We're #hiring for 3 roles:

#Independent #Researcher (PI) (Deadline: Nov 23)

#GMP #Expert (Deadline: Nov 20)

#GMP #Assistant (Deadline: Nov 20)

Check all the details in this link: ctgct.si/en/jobs